Why French Immunology Must Communicate to Lead ? Marseille, 16 February 2026 – France has long been home to outstanding immunology research. Our scientists contribute every day to advances in cancer, infectious diseases, transplantation, autoimmune disorders, and vaccine development. And yet, despite this central role, French immunology research still struggles to be recognized on the […]
Cell-Scale: A new strategic platform dedicated to Cell Therapies within MIB
Marseille, January 8, 2025 – Marseille Immunology Biocluster marks a new milestone in the development of translational immunology with the operational launch of Cell-Scale, a state-of-the-art technological platform dedicated to the engineering and development of innovative cell therapies. Designed to address the scientific and technological challenges of next-generation immunotherapies, Cell-Scale is now fully operational and […]
Welcome to Caroline Imbert, Research Engineer, Cell-Scale Platform
Holding a PhD in onco-immunology, Caroline Imbert took her first steps in innovative therapies in the United States, in Wisconsin, with ioGenetics. After studying at Paul Sabatier University (Toulouse III), she completed her doctoral research at the Toulouse Cancer Research Center, focusing on the study of antitumor immune responses and their regulation by sphingosine kinase-1 […]
An Innovative Cell Therapy for Triple-Negative Breast Cancer
During this National Breast Cancer Awareness Month, dedicated to raising awareness of breast cancer, a promising breakthrough has emerged at the CRCM – Marseille Cancer Research Center. Marseille, November 23, 2025 – Under the leadership of Prof. Daniel Olive and Dr. Marc Lopez, a team of researchers has developed a new generation of CAR-T cells […]
ImmunoSkills: €3 Million to train the immunotherapy experts of tomorrow
The ‘Campus des Métiers et des Qualifications d’Excellence’ announced on Tuesday, September 29, 2025, that the French government will provide €3 million in funding to train the next generation of immunotherapy specialists. Marseille, September 23, 2025 – The ImmunoSkills project, developed in partnership with the Marseille Immunology Biocluster (MIB), has been selected as a laureate […]
A French-American breakthrough rewrites DNA to defeat cancer
A 36-year-old American patient with stage IV colorectal cancer was facing a critical situation: all conventional treatments had failed. Today, however, she has been in complete remission for nearly two years thanks to her participation in a groundbreaking clinical trial conducted at the prestigious Masonic Cancer Center at the University of Minnesota in Minneapolis. This […]
MIB is supported by a Scientific Advisory Board of Excellence
The Marseille Immunology Biocluster (MIB) is now guided by an International Scientific Advisory Board (SAB), composed of globally recognized scientists known for their expertise and integrity. A shared expertise guiding innovation As an independent body, the SAB ensures the scientific rigor, innovation, and high standards at the core of MIB’s research projects. Chaired by Professor […]
MIB in Shanghai: The strategic role of Clinical Investigation Centers in the evolution of global healthcare
Lors du DIA China Annual Meeting 2025 à Shanghai, le Dr Daniel Olive (Professeur d’immunologie, praticien hospitalier et responsable médical, scientifique et technique de MIB) a participé à la table ronde d’ouverture aux côtés de représentants de Chine, d’Arabie Saoudite et des États-Unis. Together, they explored the role of clinical investigation centers in the […]
The MIB raises the voice of immunology at the heart of Europe
Last week in Brussels, the Marseille Immunology Biocluster (MIB) took a major step forward by asserting its presence on the European stage. During a conference dedicated to Europe’s role in life sciences, Denis Bertin, co-founder of the MIB, delivered a powerful message emphasizing the urgency of repositioning immunology as a central pillar of contemporary biomedical […]
Advancing Europe’s leadership in life science
Innovation in immunology at the heart of the European agenda On June 12, 2025, in Brussels, patient representatives, public decision-makers, industry leaders, researchers, and European representatives will come together within the European Committee of the Regions to discuss sovereignty and competitiveness drivers in healthcare. This high-level European conference, jointly organized by the Marseille Immunology Biocluster […]